Jing Dong| molecular epidemiology | Best Researcher Award
Assistant Professor,Medical College of Wisconsin, United States📖
Dr. Jing Dong is an Assistant Professor at the Medical College of Wisconsin, specializing in molecular epidemiology. With expertise in studying the molecular mechanisms of diseases, Dr. Dong has made significant contributions to understanding disease prevention and public health. Her outstanding research work has earned her the Best Researcher Award, recognizing her innovative approaches and impactful findings in the field.
Profile
Education Background🎓
Jing Dong, PhD, completed his Bachelor of Science degree at Nanjing Medical University in Jiangsu, China, from 2002 to 2007. He then pursued his PhD in Medical Sciences at the same institution, graduating in 2012.Dr. Dong’s academic career includes postdoctoral fellowships at prestigious institutions. From 2012 to 2017, he was a Postdoctoral Fellow at the Branch of Epidemiology, NIEHS/NIH, in Research Triangle Park, NC. Following this, he served as a Cancer Prevention and Research Institute of Texas (CPRIT) Postdoctoral Associate at the Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, in Houston, TX, from 2017 to 2020.
Professional Experience🌱
In 2020, Dr. Dong was appointed as an Assistant Professor in the Division of Hematology and Oncology at the Medical College of Wisconsin (MCW). He has also held roles in various collaborative initiatives such as the Community and Cancer Science Network (CCSN) and the Milwaukee Lung Cancer Collaborative Work Group. Additionally, he became a faculty member of the MCW Graduate School in 2023, qualifying as a Primary Master’s Thesis Mentor in the Precision Medicine program.
Dr. Dong’s research primarily focuses on cancer genomics, health disparities in cancer, and the genetic underpinnings of multiple myeloma and other hematologic malignancies. His work aims to uncover genetic factors contributing to cancer progression, particularly in underrepresented populations such as African Americans. He also investigates the role of mitochondrial DNA in cancer and transplant outcomes, as well as improving precision medicine through genetic data analysis.
Awards & Honors:
Throughout his career, Dr. Dong has received multiple accolades, including the IARC/WHO Summer Fellowship in Cancer Epidemiology (2010), the CPRIT-awarded Postdoctoral Associate (2017), and the Medical College of Wisconsin Cancer Center Scientific Retreat Best Poster Award (2022). He also received the Faculty Development Award from the Department of Medicine at MCW in 2023.
Skills:
Dr. Dong is highly skilled in epidemiology, cancer genomics, and bioinformatics. He has expertise in conducting large-scale genomic studies, utilizing bioinformatic tools for data analysis, and mentoring graduate students and postdoctoral fellows in cancer research. His technical skills include genomic data analysis, genetic epidemiology, and advanced statistical methods for cancer research. He is also proficient in collaborating across interdisciplinary teams, fostering significant advancements in cancer biology and treatment strategies.
1.
- Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
- Authors: LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, et al.
- Journal: Brain
- Volume: 140 (12), Pages: 3191-3203
- Year: 2017
- Citations: 420
- Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia
- Authors: Q Lan, CA Hsiung, K Matsuo, YC Hong, A Seow, Z Wang, HD Hosgood III, et al.
- Journal: Nature Genetics
- Volume: 44 (12), Pages: 1330-1335
- Year: 2012
- Citations: 346
- A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1
- Authors: Y Shi, Z Hu, C Wu, J Dai, H Li, J Dong, M Wang, X Miao, Y Zhou, F Lu, et al.
- Journal: Nature Genetics
- Volume: 43 (12), Pages: 1215-1218
- Year: 2011
- Citations: 313
- Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus
- Authors: C Zhao, J Dong, T Jiang, Z Shi, B Yu, Y Zhu, D Chen, J Xu, R Huo, J Dai, et al.
- Journal: PloS One
- Volume: 6 (8), Article e23925
- Year: 2011
- Citations: 291
- Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls
- Authors: Z Hu, J Dong, LE Wang, H Ma, J Liu, Y Zhao, J Tang, X Chen, J Dai, et al.
- Journal: Carcinogenesis
- Volume: 33 (4), Pages: 828-834
- Year: 2012
- Citations: 257
- Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma
- Authors: Y Wen, J Han, J Chen, J Dong, Y Xia, J Liu, Y Jiang, J Dai, J Lu, G Jin, et al.
- Journal: International Journal of Cancer
- Volume: 137 (7), Pages: 1679-1690
- Year: 2015
- Citations: 241
- Seminal plasma microRNAs: potential biomarkers for spermatogenesis status
- Authors: W Wu, Z Hu, Y Qin, J Dong, J Dai, C Lu, W Zhang, H Shen, Y Xia, X Wang
- Journal: Molecular Human Reproduction
- Volume: 18 (10), Pages: 489-497
- Year: 2012
- Citations: 161
- Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429, and miR-7-1-3p
- Authors: W Wu, Y Qin, Z Li, J Dong, J Dai, C Lu, X Guo, Y Zhao, Y Zhu, W Zhang, et al.
- Journal: Human Reproduction
- Volume: 28 (7), Pages: 1827-1836
- Year: 2013
- Citations: 160
- Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population
- Authors: J Dong, Z Hu, C Wu, H Guo, B Zhou, J Lv, D Lu, K Chen, Y Shi, M Chu, et al.
- Journal: Nature Genetics
- Volume: 44 (8), Pages: 895-899
- Year: 2012
- Citations: 156
- Alcohol, smoking, and risk of oesophago-gastric cancer
- Authors: J Dong, AP Thrift
- Journal: Best Practice & Research Clinical Gastroenterology
- Volume: 31 (5), Pages: 509-517
- Year: 2017
- Citations: 151
Conclusion
Dr. Jing Dong’s exceptional research expertise, leadership, mentorship, and dedication to addressing cancer health disparities make him an ideal candidate for the Best Researcher Award. His multifaceted approach to scientific inquiry and his consistent track record of high-impact publications and presentations establish him as a standout figure in his field. With further emphasis on translational research and broader public engagement, Dr. Dong has the potential to make even more profound contributions to both scientific discovery and patient care.